<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="brief-report"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">J Am Acad Dermatol</journal-id><journal-id journal-id-type="iso-abbrev">J. Am. Acad. Dermatol</journal-id><journal-title-group><journal-title>Journal of the American Academy of Dermatology</journal-title></journal-title-group><issn pub-type="ppub">0190-9622</issn><issn pub-type="epub">1097-6787</issn><publisher><publisher-name>Mosby</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">29332714</article-id><article-id pub-id-type="pmc">5785335</article-id><article-id pub-id-type="publisher-id">S0190-9622(17)32253-3</article-id><article-id pub-id-type="doi">10.1016/j.jaad.2017.08.021</article-id><article-categories><subj-group subj-group-type="heading"><subject>Article</subject></subj-group></article-categories><title-group><article-title>Oral green tea catechins do not provide photoprotection from direct DNA damage induced by higher dose solar simulated radiation: A randomized controlled trial</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Farrar</surname><given-names>Mark D.</given-names></name><degrees>PhD</degrees><xref rid="aff1" ref-type="aff">a</xref></contrib><contrib contrib-type="author"><name><surname>Huq</surname><given-names>Raqib</given-names></name><degrees>MB ChB</degrees><xref rid="aff1" ref-type="aff">a</xref></contrib><contrib contrib-type="author"><name><surname>Mason</surname><given-names>Sarah</given-names></name><degrees>PhD</degrees><xref rid="aff1" ref-type="aff">a</xref></contrib><contrib contrib-type="author"><name><surname>Nicolaou</surname><given-names>Anna</given-names></name><degrees>PhD</degrees><xref rid="aff2" ref-type="aff">b</xref></contrib><contrib contrib-type="author"><name><surname>Clarke</surname><given-names>Kayleigh A.</given-names></name><degrees>PhD</degrees><xref rid="aff3" ref-type="aff">c</xref></contrib><contrib contrib-type="author"><name><surname>Dew</surname><given-names>Tristan P.</given-names></name><degrees>PhD</degrees><xref rid="aff4" ref-type="aff">d</xref></contrib><contrib contrib-type="author"><name><surname>Williamson</surname><given-names>Gary</given-names></name><degrees>PhD</degrees><xref rid="aff3" ref-type="aff">c</xref></contrib><contrib contrib-type="author"><name><surname>Watson</surname><given-names>Rachel E.B.</given-names></name><degrees>PhD</degrees><xref rid="aff1" ref-type="aff">a</xref></contrib><contrib contrib-type="author"><name><surname>Rhodes</surname><given-names>Lesley E.</given-names></name><degrees>MD</degrees><email>lesley.e.rhodes@manchester.ac.uk</email><xref rid="aff1" ref-type="aff">a</xref><xref rid="cor1" ref-type="corresp">&#x02217;</xref></contrib></contrib-group><aff id="aff1"><label>a</label>Centre for Dermatology, Division of Musculoskeletal and Dermatological Sciences, School of Biological Sciences, Faculty of Biology, Medicine and Health, The University of Manchester, Manchester Academic Health Science Centre, Salford Royal NHS Foundation Trust, Manchester, United Kingdom</aff><aff id="aff2"><label>b</label>Division of Pharmacy and Optometry, School of Health Sciences, Faculty of Biology, Medicine and Health, The University of Manchester, Manchester Academic Health Science Centre, Manchester, United Kingdom</aff><aff id="aff3"><label>c</label>School of Food Science and Nutrition, University of Leeds, Leeds, United Kingdom</aff><aff id="aff4"><label>d</label>Department of Health Professions, Faculty of Health, Psychology and Social Care, Manchester Metropolitan University, Manchester, United Kingdom</aff><author-notes><corresp id="cor1"><label>&#x02217;</label>Corresponding author: Lesley E. Rhodes, MD, Photobiology Unit, Dermatology Centre, University of Manchester, Salford Royal NHS Foundation Trust, Manchester M6 8HD, United KingdomPhotobiology UnitDermatology CentreUniversity of ManchesterSalford Royal NHS Foundation TrustManchesterM6 8HDUnited Kingdom <email>lesley.e.rhodes@manchester.ac.uk</email></corresp></author-notes><pub-date pub-type="pmc-release"><day>1</day><month>2</month><year>2018</year></pub-date><!-- PMC Release delay is 0 months and 0 days and was based on <pub-date
						pub-type="ppub">.--><pub-date pub-type="ppub"><month>2</month><year>2018</year></pub-date><volume>78</volume><issue>2</issue><fpage>414</fpage><lpage>416</lpage><permissions><copyright-statement>&#x000a9; 2017 by the American Academy of Dermatology, Inc. All rights reserved.</copyright-statement><copyright-year>2017</copyright-year><copyright-holder>American Academy of Dermatology, Inc.</copyright-holder><license license-type="CC BY" xlink:href="http://creativecommons.org/licenses/by/4.0/"><license-p>This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).</license-p></license></permissions></article-meta></front><body><p id="p0010"><italic>To the Editor:</italic> Exposure to ultraviolet radiation (UVR) in sunlight is the principal cause of most skin cancers. Despite topical sunscreen availability, skin cancer incidence continues to rise with substantial financial burden to health care. Systemic photoprotection through safe dietary means has gained interest. Green tea catechins (GTC) administered topically or orally are chemopreventive in mouse models of UVR-induced skin cancer, potentially through reduced DNA damage or enhanced DNA repair.<xref rid="bib1" ref-type="bibr"><sup>1</sup></xref> Topical GTC protected against UVR-induced cyclobutane pyrimidine dimers (CPD) in human skin,<xref rid="bib2" ref-type="bibr"><sup>2</sup></xref> but no information exists regarding the impact of oral GTC in humans.</p><p id="p0015">We performed a double-blind, randomized, placebo-controlled trial in healthy white adults (13 male and 37 female; 18-65&#x000a0;years of age; Fitzpatrick skin phototypes I and II) who received 1080&#x000a0;mg GTC (equivalent to 5 cups/day) with 100&#x000a0;mg vitamin C (n&#x000a0;=&#x000a0;25) or placebo maltodextrin (n&#x000a0;=&#x000a0;25) daily for 12&#x000a0;weeks.<xref rid="bib3" ref-type="bibr"><sup>3</sup></xref> Vitamin C was used as previously<xref rid="bib3" ref-type="bibr"><sup>3</sup></xref> to stabilize GTC in the gut lumen.<xref rid="bib4" ref-type="bibr"><sup>4</sup></xref> A high dose proinflammatory (3 &#x000d7; minimal erythema dose [MED]) challenge with solar simulated UVR (5% UVB, 95% UVA) was applied to buttock skin pre- and postsupplementation. Immunohistochemical staining with CPD-positive cell quantification was performed in skin samples taken 24&#x000a0;hours after UVR exposure. In a further, before-after time-course pilot study, 5 subjects (2 male and 3 female; 21-31&#x000a0;years of age, Fitzpatrick skin phototype II) received GTC with vitamin C for 4&#x000a0;weeks with UVR-induced (2MED) CPD assessed pre- and postsupplementation. Urinary epigallocatechin glucuronide analysis assessed compliance.<xref rid="bib3" ref-type="bibr"><sup>3</sup></xref> CPD-positive cells/1000&#x000a0;&#x003bc;m<sup>2</sup> in UVR-irradiated epidermis postsupplementation was compared between active and placebo groups by analysis of covariance with baseline data as the covariate.</p><p id="p0020">UVR induced CPD-positive cells in the epidermis and to a much lesser extent the dermis (<xref rid="fig1" ref-type="fig">Fig 1</xref>). Following the 12-week intervention, there was no difference between active and placebo groups in number of CPD-positive cells in UVR-irradiated epidermis at 24&#x000a0;hours (<italic>P</italic>&#x000a0;=&#x000a0;.81; <xref rid="fig1" ref-type="fig">Fig 1</xref>), the active group showing mean (SD) 3.4 (1.3) cells/1000&#x000a0;&#x003bc;m<sup>2</sup> at both baseline and postsupplementation (<italic>P</italic>&#x000a0;=&#x000a0;.74), and placebo 3.7 (1.8) and 3.2 (1.5) cells/1000&#x000a0;&#x003bc;m<sup>2</sup> at baseline and postsupplementation, respectively (<italic>P</italic>&#x000a0;=&#x000a0;.20). Evaluation of a moderate (2MED) UVR dose and further time points similarly found no effect of supplement on CPD (<xref rid="fig2" ref-type="fig">Fig 2</xref>).<fig id="fig1"><label>Fig 1</label><caption><p>Ultraviolet radiation (UVR)-induced cyclobutane pyrimidine dimers (CPD) in skin from a randomized, controlled study of 12&#x000a0;weeks of supplementation with green tea catechins and vitamin C versus placebo. Representative immunohistochemistry and quantification of CPD in UVR-exposed (3&#x000a0;&#x000d7;&#x000a0;minimal erythema dose; MED) and unexposed skin at baseline and postsupplementation. Active n&#x000a0;=&#x000a0;20 subjects, placebo n&#x000a0;=&#x000a0;24 subjects. Scale bar&#x000a0;=&#x000a0;50&#x000a0;&#x003bc;m.</p></caption><graphic xlink:href="gr1"/></fig><fig id="fig2"><label>Fig 2</label><caption><p>Time course of ultraviolet radiation&#x02013;induced cyclobutane pyrimidine dimers (CPD) in skin at baseline and after 4&#x000a0;weeks supplementation with green tea catechins and vitamin C. Data are mean&#x000a0;+&#x000a0;SD number of CPD-positive cells/1000&#x000a0;&#x003bc;m<sup>2</sup> epidermis in unexposed skin (0&#x000a0;hours) and at 0.25, 6, and 24&#x000a0;hours after UVR exposure of skin. n&#x000a0;=&#x000a0;5 subjects.</p></caption><graphic xlink:href="gr2"/></fig></p><p id="p0025">Our findings contrast with oral studies in mice<xref rid="bib1" ref-type="bibr"><sup>1</sup></xref> and topical human studies which found that GTC protected against direct DNA damage.<xref rid="bib2" ref-type="bibr"><sup>2</sup></xref> Oral green tea consumption is difficult to control in mice, and topical human studies potentially have higher local skin concentrations of GTC than those after ingestion. We previously showed GTC and metabolites are bioavailable in human skin but with intersubject variability in both the range of specific metabolites and concentrations detected,<xref rid="bib5" ref-type="bibr"><sup>5</sup></xref> and further studies may&#x000a0;examine means to enhance skin uptake/bioavailability. Strengths include the robust study design, tablet count and biochemically determined subject compliance, and use of solar-simulating UVR giving more relevance to natural sun exposure than studies using primarily UVB radiation.<xref rid="bib1" ref-type="bibr">1</xref>, <xref rid="bib2" ref-type="bibr">2</xref> Our study scope is limited to erythemal UVR and direct DNA damage; we demonstrate that oral GTC is no substitute for topical sunscreen but have not excluded an adjunctive role to sunscreen. Protection against low-dose UVR exposure as in everyday life, and against oxidative DNA damage, warrants future study.</p></body><back><ref-list id="cebib0010"><title>References</title><ref id="bib1"><label>1</label><element-citation publication-type="journal" id="sref1"><person-group person-group-type="author"><name><surname>Nichols</surname><given-names>J.A.</given-names></name><name><surname>Katiyar</surname><given-names>S.K.</given-names></name></person-group><article-title>Skin photoprotection by natural polyphenols: anti-inflammatory, antioxidant and DNA repair mechanisms</article-title><source>Arch Dermatol Res</source><volume>302</volume><year>2010</year><fpage>71</fpage><lpage>83</lpage><pub-id pub-id-type="pmid">19898857</pub-id></element-citation></ref><ref id="bib2"><label>2</label><element-citation publication-type="journal" id="sref2"><person-group person-group-type="author"><name><surname>Katiyar</surname><given-names>S.K.</given-names></name><name><surname>Perez</surname><given-names>A.</given-names></name><name><surname>Mukhtar</surname><given-names>H.</given-names></name></person-group><article-title>Green tea polyphenol treatment to human skin prevents formation of UV light B-induced pyrimidine dimers in DNA</article-title><source>Clin Cancer Res</source><volume>6</volume><year>2000</year><fpage>3864</fpage><lpage>3869</lpage><pub-id pub-id-type="pmid">11051231</pub-id></element-citation></ref><ref id="bib3"><label>3</label><element-citation publication-type="journal" id="sref3"><person-group person-group-type="author"><name><surname>Farrar</surname><given-names>M.D.</given-names></name><name><surname>Nicolaou</surname><given-names>A.</given-names></name><name><surname>Clarke</surname><given-names>K.A.</given-names></name></person-group><article-title>A randomized controlled trial of green tea catechins in protection against ultraviolet radiation-induced cutaneous inflammation</article-title><source>Am J Clin Nutr</source><volume>102</volume><year>2015</year><fpage>608</fpage><lpage>615</lpage><pub-id pub-id-type="pmid">26178731</pub-id></element-citation></ref><ref id="bib4"><label>4</label><element-citation publication-type="journal" id="sref4"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>Z.</given-names></name><name><surname>Zhu</surname><given-names>Q.Y.</given-names></name><name><surname>Wong</surname><given-names>Y.F.</given-names></name></person-group><article-title>Stabilizing effect of ascorbic acid on green tea catechins</article-title><source>J Agric Food Chem</source><volume>46</volume><year>1998</year><fpage>2512</fpage><lpage>2516</lpage></element-citation></ref><ref id="bib5"><label>5</label><element-citation publication-type="journal" id="sref5"><person-group person-group-type="author"><name><surname>Rhodes</surname><given-names>L.E.</given-names></name><name><surname>Darby</surname><given-names>G.</given-names></name><name><surname>Massey</surname><given-names>K.A.</given-names></name></person-group><article-title>Oral green tea catechin metabolites are incorporated into human skin and protect against UVR-induced cutaneous inflammation in association with reduced production of pro-inflammatory eicosanoid 12-HETE</article-title><source>Br J Nutr</source><volume>110</volume><year>2013</year><fpage>891</fpage><lpage>900</lpage><pub-id pub-id-type="pmid">23351338</pub-id></element-citation></ref></ref-list><fn-group><fn id="d31e32"><p id="ntpara0010">Supported by grants from the Biotechnology and Biological Sciences Research Council, Diet and&#x000a0;Health Research Industry Club awarded to&#x000a0;Prof Rhodes (BB/G005575/1), Prof Nicolaou (BB/G005540/1), and Prof Williamson (BB/G005559/1).</p></fn><fn id="d31e35"><p id="ntpara0015">Conflicts of interest: None declared.</p></fn></fn-group></back></article>